These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11605064)

  • 41. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.
    Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH
    J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary Hypothyroidism with Exceptionally High Prolactin-A Really Big Deal.
    Khorassanizadeh R; Sundaresh V; Levine SN
    World Neurosurg; 2016 Jul; 91():675.e11-4. PubMed ID: 27155380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Total body zinc depletion and its relationship to the development of hyperprolactinemia in chronic renal insufficiency.
    Caticha O; Norato DY; Tambascia MA; Santana A; Stephanou A; Sarlis NJ
    J Endocrinol Invest; 1996; 19(7):441-8. PubMed ID: 8884538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and Radiographic Characteristics Related to Hyperprolactinemia in Nonfunctioning Pituitary Adenomas.
    Park SS; Kim JH; Kim YH; Lee JH; Dho YS; Shin CS
    World Neurosurg; 2018 Nov; 119():e1035-e1040. PubMed ID: 30144593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ectopic hyperprolactinemia resulting from an ovarian teratoma.
    Kallenberg GA; Pesce CM; Norman B; Ratner RE; Silvergerg SG
    JAMA; 1990 May; 263(18):2472-4. PubMed ID: 2329635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolactin serum level in patients with breast cancer.
    Cohen AD; Cohen Y; Maislos M; Buskila D
    Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
    Mahler C; Verhelst J; Klaes R; Trouillas J
    Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent hyperprolactinemia following mammoplasty: a rare association.
    Marino A; Patel T; Whitten E; Peiris AN
    Tenn Med; 2009 Jul; 102(7):47-8. PubMed ID: 19634649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolactin gene expression in human growth hormone-secreting pituitary adenomas.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Sugita K; Matsui N
    J Neurosurg; 1990 Jun; 72(6):879-82. PubMed ID: 2338572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperprolactinaemia as an adverse effect in regulatory and clinical toxicology: role in breast and prostate cancer.
    Harvey PW; Everett DJ; Springall CJ
    Hum Exp Toxicol; 2006 Jul; 25(7):395-404. PubMed ID: 16898168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome.
    Losa M; Mortini P; Barzaghi R; Gioia L; Giovanelli M
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3180-6. PubMed ID: 12107221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperprolactinemia during cocaine withdrawal.
    Mendelson J; Teoh S; Lange U; Mello N; Weiss R; Skupny A
    NIDA Res Monogr; 1988; 81():67-73. PubMed ID: 3136392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretion.
    Lissoni P; Barni S; Cazzaniga M; Ardizzoia A; Rovelli F; Tancini G; Brivio F; Frigerio F
    Oncology; 1995; 52(6):439-42. PubMed ID: 7478427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Luteal phase hyperprolactinemia.
    Falk RJ; Anderson L
    Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
    Huan C; Cui G; Ren Z
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma. Case report.
    Albuquerque FC; Hinton DR; Weiss MH
    J Neurosurg; 1998 Dec; 89(6):1043-6. PubMed ID: 9833836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.
    Serri O; Rasio E; Beauregard H; Hardy J; Somma M
    N Engl J Med; 1983 Aug; 309(5):280-3. PubMed ID: 6866052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.